Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This study is testing an investigational drug called TQB2934 for people with systemic light chain amyloidosis that has come back or stopped responding to prior treatments. The main goals are to find a safe and effective dose and to see if the drug can help clear the harmful prote…

This is the first study in people to test the safety of a new experimental drug called TQB2922, given as an injection under the skin. It will involve 42 adults with advanced non-small cell lung cancer who have run out of standard treatment options. The main goals are to see how s…

This study is testing an investigational injection called TQC2731 for adults with chronic sinusitis and nasal polyps. The goal is to see if the injection can safely reduce polyp size and nasal congestion over 24 weeks compared to a placebo. About 246 participants will be randomly…

This study is testing whether adding two new drugs (TQB2868 and anlotinib) to standard chemotherapy helps people with advanced pancreatic cancer live longer. About 566 participants with newly diagnosed metastatic pancreatic cancer will receive either the new drug combination or s…